Skip to content

Drug interactions

Darunavir + Metformin-repaglinide

Severity: Moderate

Darunavir and Metformin-repaglinide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Darunavir, usually boosted with ritonavir or cobicistat, inhibits CYP3A4 and can raise repaglinide levels, raising hypoglycemia risk. Protease inhibitors may also cause insulin resistance and hyperglycemia, which can reduce the effect of metformin.

What this interaction means in plain words

Darunavir and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Darunavir belongs to Anti Virals; Metformin-repaglinide belongs to Endocrine.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition (mainly from the boosting agent) raises repaglinide levels, and protease inhibitor-related insulin resistance opposes antidiabetic therapy.

What to do

Monitor blood glucose closely after starting or stopping darunavir and adjust the doses of the antidiabetic drugs as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Darunavir and Metformin-repaglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Darunavir with Metformin-repaglinide?

MediHelp rates the interaction as moderate. Darunavir and Metformin-repaglinide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Darunavir, usually boosted with ritonavir or cobicistat, inhibits CYP3A4 and can raise repaglinide levels, raising hypoglycemia risk. Protease inhibitors may also cause insulin resistance and hyperglycemia, which can reduce the effect of metformin.

How serious is the interaction between Darunavir and Metformin-repaglinide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely after starting or stopping darunavir and adjust the doses of the antidiabetic drugs as needed.

What other medicines interact with Metformin-repaglinide?

MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in